Search Results - Sanani, Shamel

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites

    Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites by Presant, Cary A, Salgia, Ravi, Kulkarni, Prakash, Tiep, Brian L, Sanani, Shamel, Leach, Benjamin, Ashing, Kimlin, Sandoval, Jossie, Sedrak, Mina S, Landau, Shana, Yeung, Sophia, Raz, Dan, Subbiah, Shanmugga

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma

    A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma by Berenson, James R., Yellin, Ori, Shamasunder, Hesaraghatta K., Chen, Chien-Shing, Charu, Veena, Woliver, Thomas B., Sanani, Shamel, Schlutz, Michael, Nassir, Youram, Swift, Regina A., Andreu-Vieyra, Claudia, Vescio, Robert

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer

    Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer by Yuan, Yuan, Lee, Jin Sun, Yost, Susan E., Stiller, Tracey, Blanchard, M. Suzette, Padam, Simran, Katheria, Vani, Kim, Heeyoung, Sun, Canlan, Tang, Aileen, Martinez, Norma, Patel, Niki Dipesh, Sedrak, Mina S., Waisman, James, Li, Daneng, Sanani, Shamel, Presant, Cary A., Mortimer, Joanne

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

    Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid by Berenson, James R., Yellin, Ori, Crowley, John, Makary, Adel, Gravenor, Donald S., Yang, Hank H., Upadhyaya, Gargi H., Flinn, Ian W., Staszewski, Harry, Tiffany, Natasha M., Sanani, Shamel, Farber, Charles M., Morganstein, Neil, Bolejack, Vanessa, Nassir, Youram, Hilger, James D., Sefaradi, Ashkan, Shamouelian, Albert, Swift, Regina A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Results of a Multi-Center, Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

    Results of a Multi-Center, Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) by Foon, Kenneth, Allen, Steven, Sen, Kaushik, Mohrbacher, Ann, Sanani, Shamel, Lenaz, Luigi, Rosales, Rosamerlinda

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

    A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) by Mohrbacher, Ann, Sanani, Shamel, Irwin, David, Espina, Byron M., Madrid, Catherine, Lenaz, Luigi, Rosales, Rosamerlinda

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: